Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2001-06-25
2003-07-01
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C514S062000, C514S561000, C514S563000, C562S567000
Reexamination Certificate
active
06585987
ABSTRACT:
This application is a 371 of PCT/IT99/00364 filed Nov. 11, 1999.
The present invention relates to complexes of hyaluronic acid and “carnitines”, the latter herein meaning both carnitine as it is and, more specifically, its acyl derivatives with straight or branched chain aliphatic carboxylic acids, optionally unsaturated or polyunsaturated, containing 2 to 20 carbon atoms.
Although the complexes according to the invention can contain, as carnitine component, DL-carnitine or D and L carnitine mixtures in variable ratios, as well as the related acyl derivatives as stated above, the preferred embodiment relates to complexes of hyaluronic acid and L-carnitine or acyl-L-carnitine, wherein “acyl” has the meanings defined above. In the present invention, “carnitine” will therefore mean, unless otherwise stated, L-carnitine; the same applies for the various acylcarnitines which will be cited in the following.
“Hyaluronic acid” will herein mean a hyaluronic acid of molecular weight ranging from about 2×10
3
to about 5×10
6
, preferably from about 2×10
5
to about 3×10
6
.
As it is obvious by what stated above, both components of the complexes according to the invention are per se known. Information concerning hyaluronic acid as well as numerous references concerning carnitine (page 281) and acetylcarnitine (page 13), can be found, inter alia, in
Merck Index
, 11
th
edition, page 751, 281 and 13, respectively; whereas acylcarnitines and/or the use thereof are the object of a number of patents (see for example U.S. Pat. No. 4,346,107, U.S. Pat. No. 4,194,006, U.S. Pat. No. 4,343,816).
The therapeutical indications of the cited components are also well known. In particular, hyaluronic acid is used as coadjuvant in the treatment of synovitis and tissutal reparation processes.
It now has been found that complexes (or even simple combinations) of hyaluronic acid and “carnitines” (which means both carnitine as it is and its acyl derivatives) can be in the form of and act as an alimentary supplement or a real medicament, depending on their favourable, preventive or therapeutical action, which said complexes or combinations are intended to exert, depending on the specific end users.
Furthermore, it has been found that said complexes and combinations can be valuable in cosmetics.
The complexes and the combinations indicated above, have, in fact: a) enhanced protective activity on tissues and cell plasmamembrane; b) antiinflammatory and radical-scavenger activities; c) anti-aging activity, in particular restoring- or maintaining-activities on skin elasticity; d) a general trophic, cosmetically remarkable, action. In particular, the complexes and the combinations according to the invention are suitable for the treatment of synovitis and gonarthrosis, Crohn's disease, ulcerous rectocolitis and celiac disease. Said activities can be more or less marked, depending on the single “carnitine” used.
Therefore a further object of the invention are pharmaceutical and cosmetic compositions containing as active ingredient: a) combinations of hyaluronic acid and carnitine or acylcarnitine, or b)—according to a preferred aspect of the invention—complexes of hyaluronic acid and carnitine or acylcarnitine, said combinations and complexes containing the two components in weight ratios ranging from 3:1 to 1:3, preferably in equiponderal ratios.
More particularly, an object of the invention are pharmaceutical compositions containing as active ingredient the combinations a) or the complexes b) above defined, with protective activity on tissues and cell plasmamembrane; with antiinflammatory and radical-scavenger activities; for the therapy of synovitis and gonarthrosis; for the therapy of Crohn' disease, ulcerous rectocolitis and celiac disease; moreover, cosmetic compositions containing the combinations a) or the complexes b), with anti-aging activity, and restoring- and maintaining-activities on skin elasticity and general trophic action.
As already mentioned, carnitine and acylcarnitines contained in the above mentioned pharmaceutical and cosmetic compositions are preferably L-carnitine and acyl-L-carnitine. Particularly preferred are acetyl-L-carnitine, propionyl-L-carnitine and palmitoyl-L-carnitine.
The complexes of the invention contain the two components in weight ratios ranging form 1:3 to 3:1, preferably in equiponderal ratios. They are obtained by: a) addng hyalluroinic acid to a suspension or solution of acylcarnitine (or carnitine) in ethanol/PBS (phosphate-buffered saline), under stong stirring, at a temperature of 20-60° C., preferably about 50° C., or b) adding acylcarnitine (or carnitine) to a solution of hyaluronic acid in PBS, subjecting the shole first to sonication at temperatures ranging between 10 and 30° C., preferably at 15-20° C., thn to centrifugation, with recovery of the supernatant. The resulting product has been proved to be a real complex by means of the chemico-physical detrminations which will be described in the folwing.
REFERENCES:
patent: 5442053 (1995-08-01), della Valle et al.
patent: 5922331 (1999-07-01), Mausner
patent: 663 616 (1965-09-01), None
patent: 0 951 909 (1999-10-01), None
patent: 2609393 (1988-07-01), None
patent: WO95/05168 (1995-02-01), None
Wenninger J. A.: “International Cosmetic Ingredient Dictionary and Handbook (vol. 3)”, The Cosmetic Toiletry and Fragrance Association, Washington, p. 1878, column 2 1997.
Patent Abstracts of Japan vol. 1995, No. 07, Aug. 1995 & JP07 097401 (Shiseido Co Ltd), Apr. 1995.
Boehm K. A. et al.: “Carnitine: A Review for the Pharmacy Clinician” Hospital Pharmacy, US, Lippincott, Philadelphia, vol. 28, No. 9, Sep. 1993, pp. 843, 847-850.
Patent Abstracts of Japan vol. 014, No. 242, May 1990 & JP02 062814 (Chisso Corp), Mar. 1990.
Continental Projects Limited
Nixon & Vanderhye P.C.
Richter Johann
Zucker Paul A.
LandOfFree
Complexes of hyaluronic acid/carnitines and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complexes of hyaluronic acid/carnitines and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complexes of hyaluronic acid/carnitines and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3101417